News

DCRL Research: Impact of different training modalities on high-density lipoprotein function in HFpEF patients: a substudy of the OptimEx trial

Pamela W. Sowa1, Ephraim B. Winzer1, Jennifer Hommel1, Anita Männel1, Emeline M. van Craenenbroeck2,3,
Ulrik Wisløff4, Burkert Pieske5, Martin Halle6,7, Axel Linke1 and Volker Adams1,8*
1Laboratory of Molecular and Experimental Cardiology, Technische Universität Dresden, Heart Center Dresden, Dresden, Germany; 2Research Group Cardiovascular Diseases,
GENCOR, University of Antwerp, Antwerp, Belgium; 3Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium; 4The Cardiac Exercise Research Group at
Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway; 5Department Internal Medicine and Cardiology,
Campus Virchow Klinikum, Charité Universitätsmedizin Berlin, Berlin, Germany; 6Department of Prevention and Sports Medicine, University Hospital Klinikum rechts der Isar,
Technical University of Munich, Munich, Germany; 7DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany; and 8Dresden
Cardiovascular Research Institute and Core Laboratories GmbH, Dresden, Germany